Ammar Sukari MD

Breast Cancer, Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Professor of Oncology Medical Oncology division chief, Wayne State University School of Medicine Team Leader, Head and Neck MDT, Karmanos Cancer Institute Medical Director, Karmanos Cancer Network

Join to view full profile

31995 Northwestern HighwayFarmington, MI 48334
Phone+1 800-527-6266
Fax+1 313-576-8767

Dr. Sukari is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sukari's full profile Already have an account?

Summary

I am a Professor in the department of Oncology, School of Medicine, Wayne State University. My main areas of interest are immuno-oncology, head and neck cancer and thoracic oncology. I am the head and neck multi-disciplinary team leader at Karmanos Cancer Institute (KCI) since 2014. I am a member of Eisenberg Center for Translational Therapeutics.

Education & Training

Corewell Health William Beaumont University HospitalFellowship, Medical Oncology, 2004 - 2006
Corewell Health William Beaumont University HospitalResidency, Internal Medicine, 2001 - 2004
University of Aleppo Faculty of MedicineClass of 1999

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CO State Medical License 2025 - 2027
MI State Medical License 2005 - 2027
OH State Medical License 2024 - 2026
FL State Medical License 2014 - 2018
American Board of Internal Medicine Medical Oncology

Clinical Trials

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
COMPLETED
PHASE2
T-cell Based Immunotherapy for Head and Neck Cancer
WITHDRAWN
PHASE1
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
COMPLETED
PHASE1, PHASE2

Publications & Presentations

PubMed

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.
Barbara Burtness, Ari J Rosenberg, Benoit Calderon, Sun Min Lim, Muh-Hwa Yang
Journal of Clinical Oncology. 2026-08-20
Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical Trial.
Sheila H Ridner, Derek K Smith, Cristina M Kline-Quiroz, Katrina M Jensen, Ammar W Sukari
International Journal of Radiation Oncology, Biology, Physics. 2026-08-03
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Amaury Daste, Xiuning Le, Amani Makkouk, Maulik Patel, Christophe Le Tourneau
Journal for Immunotherapy of Cancer. 2026-04-09

Journal Articles

Role of F-BOX proteins in Cancer Cachexia and Muscle Wasting
A Sukari, I Muqbil, P Trilokia, PA Philip, A Azmi, Seminars in Cancer Biology, 1/1/2016
Concurrent Chemoradiation Improves Survival in Hypopharyngeal Cancer
P.A. Paximadis, T. Kumar, G. Yoo, H.S. Lin, J. Jacobs, A. Sukari, Z. Kafri, W. Yoo, A. Konski, H. Kim, International Journal of Radiation Oncology*Biology*Physics, 1/1/2010

Books/Book Chapters

Chemotherapy in head and neck cancers
Chapter: Targeting Oral Cancer
D. Burchhardt, A. SukariSpringer2015

Abstracts/Posters

Preliminary results from KEYNOTE-055: Pembrolizumab after platinum and cetuximab failure in head and neck squamous cell carcinoma (HNSCC)
J Bauml, T Y. Seiwert, D G. P fister, F P. Worden, S V. Liu, J Gilbert, N F. Saba, J Weiss, L J. Wirth, A Sukari, H Kang, M K. Gibson, E Massarelli, S F Powell, A Meis..., J Clin Oncol, 1/1/2016
Definitive concurrent chemoradiotherapy (CRT) for locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) using systemic dose carboplatin: A retrospec...
M Nagasaka, M A. Zaki, M Issa, H E. Kim, J Abrams, A Sukari, Annual ASCO Meeting, 1/1/2016
A phase 2 trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed platinum and...
S Powell, S Liu, A Sukari, C Chung, J Bauml, R Haddad, C Gause, M Niewood, L Gammage, H Brown, A Meister, J Cheng, M Gitau, ASCO Annual Meeting, 1/1/2015

Lectures

How Can We Predict Who Will Respond to Checkpoint Inhibitors?
Wayne State University - 1/19/2016
The potential breakthrough in management of Head & Neck Cancers through checkpoint inhibitors
Wayne State University - 1/15/2016
The Future of Oncology; Cancer Immunotherapy in Head & Neck Cancer
Petoskey, MI - 1/14/2016

Authored Content

Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformationNovember 2018

Press Mentions

Karmanos Cancer Institute Highlights Symptoms to Not Ignore During Head and Neck Cancer Awareness MonthApril 14th, 2025
Karmanos Cancer Institute Opens Medical Oncology Clinic in RosevilleJanuary 24th, 2023
Karmanos Cancer Institute Opens Roseville Medical Oncology Clinic, Welcomes New OncologistJanuary 23rd, 2023